Market News

Piper Sandler analyst Rob Owens maintains Atlassian (NASDAQ:TEAM) with a Overweight and raises the price target from $175 to $190.

Needham analyst Mike Matson maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $64.

Needham analyst Sean Milligan initiates coverage on Fervo Energy (NASDAQ:FRVO) with a Buy rating and announces Price Target of $17.

Rosenblatt analyst Kevin Cassidy maintains Microchip Technology (NASDAQ:MCHP) with a Buy and lowers the price target from $120 to $115.

Needham analyst N. Quinn Bolton maintains Quantinuum (NASDAQ:QNT) with a Buy and lowers the price target from $100 to $60.

Rosenblatt analyst Mike Genovese maintains Applied Optoelectronics (NASDAQ:AAOI) with a Buy and lowers the price target from $220 to $115.

Clover Health demonstrates robust membership and revenue growth, turning GAAP profitable with improving cohort economics. Learn why CLOV stock is a st...

Solana co-founders Anatoly Yakovenko (Toly) and Raj Gokal appear to have made a major push into consumer-facing applications. The duo have announced t...

Needham analyst John Todaro maintains Core Scientific (NASDAQ:CORZ) with a Buy and lowers the price target from $35 to $28.

Jones Trading analyst Matthew Erdner maintains FrontView REIT (NYSE:FVR) with a Buy and lowers the price target from $21 to $20.

Needham analyst David Williams maintains Diodes (NASDAQ:DIOD) with a Buy and lowers the price target from $110 to $100.

Freedom Capital Markets analyst Lemar Clarke maintains Chime Financial (NASDAQ:CHYM) with a Buy and raises the price target from $32 to $40.

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-...

Royalty Pharma has delivered strong share price gains in recent years, and that kind of run always raises a practical question for investors who look ...

Invsting.com -- Rightmove (LON:RMV) upgraded its full-year underlying earnings per share growth forecast on Friday, while keeping its revenue and oper...

CleanSpark has come under pressure as bitcoin’s drop below US$76,000 weighs on mining revenues, while a Texas-focused downgrade highlights fresh regul...

Needham analyst Ryan MacDonald maintains Veeva Systems (NYSE:VEEV) with a Buy and raises the price target from $310 to $360.